* Context Therapeutics press release [https://seekingalpha.com/pr/20295545-context-therapeutics-reports-third-quarter-2025-operating-and-financial-results] (CNTX [https://seekingalpha.com/symbol/CNTX]): Q3 GAAP EPS of -$0.10 misses by $0.01.
* Cash and cash equivalents were $76.9 million at September 30, 2025, compared to $94.4 million at December 31, 2024.
MORE ON CONTEXT THERAPEUTICS
* Seeking Alpha’s Quant Rating on Context Therapeutics [https://seekingalpha.com/symbol/CNTX/ratings/quant-ratings]
* Historical earnings data for Context Therapeutics [https://seekingalpha.com/symbol/CNTX/earnings]
* Financial information for Context Therapeutics [https://seekingalpha.com/symbol/CNTX/income-statement]
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01
Published 2 days ago
Nov 6, 2025 at 2:21 PM
Negative
Auto